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Abstract
Background Weight regain due to gastric pouch dilatation af-
ter Roux-en-Y gastric bypass (RYGB) is seen more frequently
after long-term follow-up. We studied the feasibility and safe-
ty of laparoscopic pouch resizing (LPR) for dilated gastric
pouch after RYGB associated with inadequate weight loss.
Methods From 1st June 2011 to 1st September 2013, patients
who underwent LPR after failed RYGB were retrospectively
compared and analyzed. Data included patient demographics,
comorbidity, indication for revision, preoperative weight and
BMI, operative time, hospital stay, conversion rate, mean fol-
low-up, body mass index (BMI) loss, percentage excess
weight loss (%EWL), reoperation rate, morbidity, and
mortality.
Results Out of 170 revisional bariatric procedures, 32 LPR
(27/5, F/M) were performed for dilated gastric pouch after
RYGB. The mean age, preoperative weight, and BMI were
38.3±9.3 years, 101.7±22.8 kg, 38.8±6.4 kg/m2, respective-
ly. The median operative time and hospital stay were 100 min
and 2 days, respectively. All pouch resizing procedures were
carried out laparoscopically, with none requiring conversion
to open surgery. The overall complication and reoperation
rates were 15.6 and 3.1 %, respectively. There were no deaths.
The mean follow-up was 14.1±6.2 months. The mean post-
operative BMI was 32.8±7.3 kg/m2, and the median %EWL
was 29.1 %.
Conclusions LPR is safe and can lead to adequate weight loss.
However, long-term follow-up is needed to determine the ef-
ficiency and durability of this procedure.
Keywords Laparoscopy . Gastric pouch reduction . Gastric
bypass . Revisional
Introduction
Bariatric surgery has been shown to be most effective in
achieving weight loss and improving comorbidities in mor-
bidly obese patients [1–3], success being defined when ≥50%
excess weight loss (EWL) has been achieved, eventually as-
sociated with resolution of obesity-related comorbidities
[4–6]. When patients were followed for at least 10 years,
long-term failure rates, however, can be as high as 20.4 %
after RYGB in morbidity obese patients and 34.9 % in super
obese patients [7].
Inadequate weight loss is the primary indication for
revisional bariatric surgery [8–10] procedures that include
lengthening of the Roux limb, correction of large gastric
pouch and stoma, and takedown of gastric-gastric fistula, the
principal reasons for insufficient weight loss or weight regain
[11].
Elongating the Roux limb has been shown to correct failed
weight loss in super obese patients but requires nutritional
support to prevent protein-calorie malnutrition, iron and vita-
min deficiency [12, 13]. This has led to consider other options
such as placing a band on the gastric pouch or conversion to
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biliopancreatic diversion and duodenal switch (BPD-DS)
[14], shown to be more effective than Roux-en-Y bypass [15].
Revisional bariatric surgery, however, has been associated
with high morbidity and mortality [16–18]. Less invasive pro-
cedures, such as the endoscopic transoral gastric plication
(EGP) with the StomaphyX™ device (EndoGastric
Solutions, Redmond City, WA), can reduce the size of the
gastric pouch and the gastrojejunostomy. Although weight
loss is maximal during the first 6 months with 19.5 % EWL
at 1-year follow-up [19], weight loss has been reported to
decrease on long-term follow-up: Both the pouch and stoma
tend to regain their preprocedure size [20].
The literature on the benefits of LPR diverges: considered
safe and effective in terms of %EWL by some [21], LPR was
not found to offer any major therapeutic benefit by others [14].
In the present study, we retrospectively evaluated weight
loss and complication rates after LPR in a consecutive series
of bariatric surgery patients undergoing revisional surgery for
failure of weight loss.
Material and Methods
Data from all patients undergoing revisional bariatric surgery
were reviewed. Out of 170 revisional bariatric procedures, 32
LPR (27/5, F/M) were performed for failure of weight loss
(and dilated gastric pouch) after RYGB and form the study
population.
Patient demographics, comorbidities, indication for revi-
sion, preoperative weight and BMI, operative time, hospital
stay, conversion rate after LPR, overall mean follow-up, body
mass index (BMI) loss, percentage excess weight loss
(%EWL), indications for surgery, reoperation rate, morbidity,
and mortality were reviewed and compared.
Preoperative Assessment
All patients underwent preoperative routine blood tests, ultra-
sound examination (US) of the liver and gallbladder, barium
upper gastrointestinal (GI) contrast studies and gastroscopy to
evaluate gastric pouch for dilatation, stoma size, and the pres-
ence of gastro-gastric fistula. Patients were offered surgical
correction if the pouch was larger than 30 cc, or the stoma is
wider than 1.5 cm, as assessed by radiology and gastroscopy,
or the upper part of the pouch was visible during endoscopic
retroversion. If gallstones were found, cholecystectomy was
performed at the time of revision for both symptomatic and
asymptomatic patients. Patients with fatty liver found on US
examination were put on high-protein, low-carbohydrate diet
2 to 4 weeks prior to surgery to help reduce liver size. All
patients who were positive for Helicobacter pylori were treat-
ed preoperatively with appropriate antibiotics. Sleep apnea
was searched for routinely.
Surgical Technique
All patients received preoperative low molecular weight hep-
arin in addition to continuous pneumatic compression stock-
ing application during surgery. Prophylactic antibiotics were
given preoperatively and continued until patient discharge.
LPR
Laparoscopic pouch resizing was performed using a 4–5 port
technique (5–12 mm, Excell, Ethicon Endosurgery,
Cincinnati, OH, USA). Pneumoperitoneum was established
with a Veress needle inserted in the left subcostal area. The
left liver lobe was retracted by the shaft of a 5-mm grasper,
placed via a 5-mm trocar inserted in the subxiphoid position.
Adhesions between the gastric pouch, Roux-en-Y limb,
and undersurface of the liver were dissected completely. The
posterior wall of the pouch and Roux-en-Y limb were dissect-
ed free in the direction of the left crus to avoid leaving a large
pouch on the posterior wall. A 36 F bougie was then inserted
orally by the anesthetist into the jejunum and under laparo-
scopic guidance. A new 20–25-cc gastric pouch was created
by LPR using serial green loads (60 mm, Ethicon
Endosurgery, Cincinnati, OH, USA) starting from the dilated
Roux loop and across the gastrojejunostomy and gastric
pouch up to the gastroesophageal junction. The restapling
included 10 cm of the Roux limb, the gastrojejunal anastomo-
sis, and the dilated gastric pouch (Figs. 1, 2 and 3). One patient
with a large pouch leading to regain of weight also had a
marginal ulcer. We also included one patient with gastro-
gastric fistula because this patient also had weight regain
and a large pouch. The gastrojejunostomy anastomosis was
taken down for the patient with the marginal ulcer, and the
ulcer was excised with LPR, and the anastomosis was
refashioned. Furthermore, the patient with gastro-gastric fistu-
la underwent LPR and excision of the fistula complex. The
staple line was then oversewn with continuous absorbable
sutures in all patients. Methylene blue was injected into the
Fig. 1 New pouch and resected pouch
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nasogastric tube to check for intraoperative leak in all patients.
A closed suction drain was inserted routinely.
Patients were discharged on the second postoperative day if
there was no evidence of sepsis and if they tolerated oral
intake.
Patients were requested to take proton pump inhibitor treat-
ment postoperatively for 3 months. One week after surgery, all
patients were also given multivitamins, calcium, iron, and
vitamin B12.
Study Design
Data were collected and analyzed using SPSS 22.0 for win-
dows (Statistical Package for Social Science, Chicago, IL,
USA).
Results
The median operative time and hospital stay were 100 min
(range 50–210 min) and 2 days (range 2–5 days), respectively.
None of our patients were converted to open.
The overall complication and reoperation rates were 15.6
and 3.1 %, respectively. One patient sustained a postoperative
superficial surgical site hematoma at the stapler port site, re-
quiring operative evacuation and blood transfusion under gen-
eral anesthesia. One patient developed postoperative chest in-
fection and was treated with antibiotics. One patient de-
veloped an incisional hernia which was repaired at a
later stage. Marginal ulcer was seen in one patient post-
operatively who responded to conservative medical
treatment.
One patient required several reoperations. She presented
1 week postoperatively with intestinal obstruction and port
site hernia. CT scan confirmed the clinical findings and re-
vealed left subphrenic collection; however, there was no evi-
dence of leak even after oral contrast study. She underwent
laparotomy and was found to have staple line disruption at the
distal stomach in addition to port site hernia that caused intes-
tinal obstruction. This patient had required partial resection of
the distal stomach which was seen to be poorly vascularized at
the end of LPR procedure. The left subphrenic collection was
drained. The pouch staple line was inspected, and there was no
leak. She was discharged from the hospital with wound infec-
tion. One month later, she presented with fever and sepsis. CT
scan revealed a left subphrenic collection, and oral contrast
study did not show evidence of leak. It was drained percuta-
neously. However, 2 days later, she required surgical explora-
tion for pouch leak, where only two drains were inserted. A
few days later, a stent was inserted by the gastroenterologist
and was kept for 8 weeks. Nasojejunal tube feeding was given
until the stent was removed. She developed minor
gastrocutaneous fistula that healed after conservative treat-
ment. There was no mortality in our study group.
Compliance with postoperative vitamin intake was seen in
57.1 % after LPR (Table 1).
Ten out of 32 patients had obesity-related comorbidities
prior to RYGB, including type II diabetes mellitus (TIIDM),
hypertension, and obstructive sleep apnea (OSA). All patients
with hypertension (2/2) and OSA (1/1) resolved after the pri-
mary RYGB. TIIDM resolved in only three (out of four) pa-
tients; one patient was still on treatment at the time of LPR. He
was lost to follow-up after LPR. Of three patients with bron-
chial asthma that did not resolve after RYGB, one (1/3) re-
solved after LPR.
The mean age, preoperative weight, and BMI prior to LPR
was 38.3±9.3 years, 101.7±22.8 kg, 38.8±6.4 kg/m2, respec-
tively (Table 2). The initial weight and BMI prior to primary
RYGB was 133.3±24.6 and 50.7±7.4 kg/m2, respectively.
The total weight loss and BMI reduction after the primary
gastric bypass were 31.6 kg and 12.4 kg/m2, respectively,
and the median %EWL was 42.6 % (range 1.1–75.5).
After a mean follow-up of 14.1±6.2 months after LPR, the
mean postoperative weight and BMI were 87.8±21.8 and
32.8±7.3 kg/m2, respectively, and the median %EWL was
29.1 % (range 0–99 %) (Table 3). Thus, the total weight loss
and BMI reduction after the LPR were 13.9 kg and 5.5 kg/m2,
Fig. 2 Resected pouch and posterior wall
Fig. 3 Staple line reinforcement with suture
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respectively, and the total median %EWL from the primary
RYGB until after LPR was 71.7 %.
Discussion
While the literature differs as to the benefits of pouch resizing
[11, 21–27], we have shown that LPR leads to a median
%EWL of 29.1 % and that the total median %EWL from the
primary RYGB until after LPR was 71.7 %.
Failure of weight loss or weight regain after bariatric sur-
gery is multifactorial. Nutritional and psychological factors
should be excluded prior to anatomic evaluation. Pouch size,
gastrojejunal anastomosis diameter, and length of
biliopancreatic and alimentary limbs are the most important
anatomic causes. Because the malabsorptive component of
RYGB undergoes adaptive mechanisms over time, it has been
shown that there was no significant difference between short
and long limb RYGB after long-term follow-up [7]. Other
authors have shown that elongating the Roux limb corrected
failed weight loss in super obese patients but required nutri-
tional support to prevent protein-calorie malnutrition, iron and
vitamin deficiency [12, 13]. Furthermore, Näslund showed
almost 30 years ago that patients after gastroplasty with small-
er stoma lost more weight than those with larger stoma while
after gastric bypass, no such correlation was found [22].
Different techniques have been suggested to assess the size
of the gastric pouch, but no ideal method has yet been defined
[21, 23–25]. In our series, we preferred to use endoscopic and
contrast study assessment (>30 cc, or stoma wider than
1.5 cm, or the upper part of the pouch visible during retrover-
sion). We found this method of assessment easy and practical
to follow.
Due to the major complications associated with reoperative
surgery, a transoral method to treat failure of weight loss or
weight regain could potentially eliminate the risks of anasto-
motic leak and bleeding. Mikami et al. performed
Stomaphyx™ on 39 patients and reported 17.0 % (14/39)
and 19.5% (6/39) EBWL at 6 months and 1 year, respectively,
without morbidity. However, many patients were lost to
follow-up at 6 months and 1 year. Resolution of diarrhea
was seen in three patients, and improvement of gastroesoph-
ageal reflux was seen in eight patients (19). Ong’uti et al.
performed Stomaphyx™ on 27 patients. Only 18/27 patients
had >6-month follow-up. Themedian%EWLwas <47%, and
most of their patients reached the maximum weight loss at
6 months, reaching a plateau or beginning to regain some
weight after 6 months. Twelve of 14 (86 %) of their patients
regained weight by the end of the first year, and they conclud-
ed that initial weight loss could have been due to diet modifi-
cation and close monitoring [20]. A recent review has shown
that while these procedures could be of interest in certain
cases, their efficacy is limited, and most of the devices are
short lived and no longer available [26].
Our technique of LPR is similar to what has been described
earlier in the literature. We resize the alimentary limb,
gastrojejunostomy, and gastric pouch over a calibration tube
Table 1 Conversion, complications, and reoperation
Clinical characteristics LPR
n %
Operative time (min) (median, range) 100 50–210
Hospital stay (days) (median, range) 2 2–5
Conversion 0 0.0
Complications rate 5 15.6
Reoperation rate 1 3.1
Complications
Wound hematoma 1 3.1
Leak 1 3.1
Incisional hernia 1 3.1
Chest infection 1 3.1
Marginal ulcer (post-LPR) 1 3.3
Compliance with vitamin intake 16/28 57.1
Table 2 Demographic data
Clinical characteristics LPR
n %




Preoperative weight (kg) (mean±SD) 101.7 ±22.8
Preoperative BMI (kg/m2) (mean±SD) 38.8 ±6.4
Comorbidities
Diabetes mellitus (pre-RYGB) 4 12.5
Hypertension (pre-RYGB) 2 6.3
Obstructed sleep apnea (pre-RYGB) 1 3.1
Bronchial asthma (pre-RYGB) 3 9.4
Indications
Inadequate weight loss/weight regain 30 93.8
Marginal ulcer (pre-LPR) 1 3.1
Gastro-gastric fistula 1 3.1
Table 3 Follow-up
Overall follow-up (months) (mean±SD) 14.1±6.2
Overall follow-up weight (kg) (mean±SD) 87.8±21.8
Overall follow-up BMI (kg/m2) (mean±SD) 32.8±7.3
Overall follow-up %EWL (median, range) 29.1 % (0–99 %)
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without having to redo the anastomosis to avoid the risk of
anastomotic leak [14]. Iannelli et al. did not refashion the
gastrojejunal anastomosis because they performed a tightly
calibrated anastomosis (10 mm) at primary surgery, and dur-
ing endoscopy at the time of revision, the stoma was <15 mm
[21]. They showed that pouch resizing after RYGB was fea-
sible laparoscopically in 90 % of patients and the EWL was
75, 72.2, and 68.6 % at 6-, 12-, and 18-month follow-up,
respectively. They also showed that patients with primary di-
lated pouch had significantly better results than patients with
secondary dilated pouch. However, their complication rate
was 30 % (21). Parikh et al. reported poor results at 1-year
follow-up [14]. The BMI decrease was 2.7 kg/m2, and EWL
was 12.8 % and even after separately evaluating those patients
who underwent Roux limb lengthening (5/14 patients).
Furthermore, the bougie size used ranged between 32Fr-60
Fr, and this may explain the low decrease in BMI and EWL.
Müller et al. demonstrated the feasibility of laparoscopic
pouch resizing and redo pouch-jejunal anastomosis with low
morbidity in five patients. The median BMI decreased from
32.0 to 28.0 kg/m2 at a median follow-up of 12 months, and
diabetes improved in four patients [25]. Hamdi et al. have
shown statistically significant weight loss at 3, 6, 9, and
12 months after revisional surgery for gastric pouch and
gastrojejunal anastomosis in patients with weight regain after
gastric bypass. However, there was no statistically significant
weight loss at 24 months in spite of BMI reduction from 54.6
to 44.2 kg/m2 [27]. In our study, BMI reduction after LPR
dropped from 38.3 to 32.8 kg/m2 over a mean follow-up of
14.1months. Our median%EWLwas 29.1%.We believe that
it is crucial to dissect the posterior wall of the gastric pouch
from adhesions, since it tends to dilate over time and to use
lower bougie size (36 Fr) (reviewer no. 1). Since most of our
patients were carbohydrate eaters, we did not lengthen the
Roux limb because of concerns about protein malnutrition.
Furthermore, compliance with vitamin intake was 57.1 %.
Our morbidity rate after LPR was consistent with other
published series [27]. We had no leaks attributable to LPR
although one patient had a complicated course secondary to
port site hernia and intestinal obstruction that led to staple line
dehiscence at the remnant distal stomach after LPR.
However, our results must be interpreted with caution. Our
series is relatively small, retrospective, monocentric, with
short follow-up.
In conclusion, the exact reasons for weight loss failure after
Roux-en-Y gastric bypass remain incompletely elucidated and
are probably multifactorial. There is a need to determine the
best way to evaluate pouch size as well as the long-term out-
come of LPR, as compared to other techniques after Roux-en-
Y failure such as Roux limb lengthening, placing an adjust-
able gastric band on the pouch, or converting the patient to a
BPD-DS [12, 13. 14, 15]. Proper evaluation of all therapeutic
modalities to correct Roux-en-Y failure (including LPR)
remain. Proper preoperative vitamin and mineral intake eval-
uation is essential if limb lengthening is considered.
Furthermore, patients should be informed well about possible
protein-calorie malnutrition risks following such procedure.
Last, precisions as to Roux limb length at initial surgery might
also be important to consider.
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